| (210) | Number of the EPO application | 15797767 |
| (220) | Filing date of the EPO application | 2015.11.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 20/2020, 2020.05.13 |
| (110) | EPO patent number | 3218403 |
| (21) | Number of the application | e 2017 0085 |
| (71) | Name(s) of applicant(s), code of the country | F. Hoffmann-La Roche AG, CH; |
| (72) | Name(s) of inventor(s), code of the country | HASS Philip E., US;
HAZEN Meredith, US;
HSIAO Yi-Chun, US;
KHOSLA Rajita, US;
NAKAMURA Gerald R., US;
SESHASAYEE Dhaya, US;
VAN LOOKEREN CAMPAGNE Menno, US;
XI Hongkang, US;
ZHAI Wenwu, US;
BEVERS Jack III, US;
CHIANG Nancy, US; |
| (73) | Name(s) of owner(s), code of the country | F. Hoffmann-La Roche AG, CH; |
| (54) | Title of the invention | ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/24 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2017.10.31 |
| (30) | Priority | 201462077876 P, 2014.11.10, US; 201562165732 P, 2015.05.22, US |
| (86) | International application | PCT/US2015/060008, 2015.11.10 |
| (87) | International publication | WO 2016/077381, 2016.05.19 |